According to DelveInsight, the market of DiabeticPeripheralNeuropathy in 7MM was found to be approximately USD 2,275.52 Million in 2017.
Among 7MM, the United States had the highest prevalent population of Diabetic Peripheral Neuropathy with about 12,522,483 cases in 2017.
Among EU5 countries, Germany had the highest prevalent cases with 3,904,730 cases, followed by Italy.
However, Spain registered the least number of diagnosed prevalent cases. All these cases are expected to increase by 2030.
Some of the key players in Diabetic Peripheral Neuropathy Market includes Helixmith, Aptinyx Inc., WinSanTor, Regenacy Pharmaceuticals LLC, Novaremed AG, Grünenthal GmbH, Glenmark Pharmaceuticals, and others.
For more information visit: https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
#PeripheralNeuropathy #healthcare #biotechnology #pharmaceutical #lifescience #medical #marketresearch #market #consulting #neuropathy #diabetes